Matches in Wikidata for { <http://www.wikidata.org/entity/Q69687173> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q69687173 description "artikull shkencor i botuar më 01 janar 1987" @default.
- Q69687173 description "artículu científicu espublizáu en xineru de 1987" @default.
- Q69687173 description "im Jahr 1987 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69687173 description "scientific article published on 01 January 1987" @default.
- Q69687173 description "wetenschappelijk artikel" @default.
- Q69687173 description "наукова стаття, опублікована в січні 1987" @default.
- Q69687173 name "Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial" @default.
- Q69687173 name "Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial" @default.
- Q69687173 name "Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial" @default.
- Q69687173 type Item @default.
- Q69687173 label "Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial" @default.
- Q69687173 label "Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial" @default.
- Q69687173 label "Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial" @default.
- Q69687173 prefLabel "Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial" @default.
- Q69687173 prefLabel "Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial" @default.
- Q69687173 prefLabel "Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial" @default.
- Q69687173 P1433 Q69687173-B4579F47-FB96-47D9-8CD2-86450A40CD10 @default.
- Q69687173 P1476 Q69687173-E611B1AB-EDD8-4D84-946D-EBFC8BB71CB4 @default.
- Q69687173 P2093 Q69687173-2D91A560-3B51-4858-87E9-1912D7A6FCED @default.
- Q69687173 P2093 Q69687173-A406C986-4B69-4C3A-B21A-BDD49E36333B @default.
- Q69687173 P2093 Q69687173-A92EF24A-FA79-40C4-9A27-5E4A3B7C0C5D @default.
- Q69687173 P2093 Q69687173-F6206811-893D-475B-83D6-B45110C6FA56 @default.
- Q69687173 P304 Q69687173-50F34879-2E4A-4C79-A12D-F14E7737D47A @default.
- Q69687173 P31 Q69687173-D4202891-92EC-4B1E-8C48-3899F6E433E1 @default.
- Q69687173 P433 Q69687173-58A14441-132A-4613-A4E3-FC55BAD8B91C @default.
- Q69687173 P478 Q69687173-45AA63E9-2914-43CC-BD6E-9D0E64D7E656 @default.
- Q69687173 P577 Q69687173-5E578053-8610-48B5-AA4E-A08B245CD5B0 @default.
- Q69687173 P698 Q69687173-8F31DC36-D5F1-4775-AB37-6608E627773B @default.
- Q69687173 P921 Q69687173-3AE4FEA8-A16D-4BF9-8B42-BF1030D61E9C @default.
- Q69687173 P921 Q69687173-6ADD1DD8-9161-4C8B-9DDF-3BF0B3058236 @default.
- Q69687173 P698 3791273 @default.
- Q69687173 P1433 Q27710285 @default.
- Q69687173 P1476 "Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial" @default.
- Q69687173 P2093 "Birch R" @default.
- Q69687173 P2093 "Graham SD" @default.
- Q69687173 P2093 "Irwin L" @default.
- Q69687173 P2093 "Moore MR" @default.
- Q69687173 P304 "89-90" @default.
- Q69687173 P31 Q13442814 @default.
- Q69687173 P433 "1" @default.
- Q69687173 P478 "71" @default.
- Q69687173 P577 "1987-01-01T00:00:00Z" @default.
- Q69687173 P698 "3791273" @default.
- Q69687173 P921 Q181257 @default.
- Q69687173 P921 Q42824440 @default.